Patents by Inventor Federico Gomez

Federico Gomez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11151097
    Abstract: Techniques and technologies for dynamic schema determination and enforcement are described. In at least some embodiments, a system comprises: a processing component; and a schema determination and enforcement component configured to receive a first data unit; analyze the first data unit to determine an inferred data schema; receive a second data unit; analyze the second data unit to determine whether the second incoming data unit complies with the inferred data schema; if the second data unit complies with the inferred data schema, write the second data unit to storage; and if the second data unit does not comply with the inferred data schema, at least one of: modify the inferred data schema based on the second data unit; or provide a notification of a non-compliance of the second data unit.
    Type: Grant
    Filed: September 25, 2016
    Date of Patent: October 19, 2021
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Daron Spektor, Ryan E. Gregg, Federico Gomez Suarez, David G. Porter
  • Publication number: 20210045395
    Abstract: A method for extending shelf life of a biological soft tissue of an object includes introducing one or more cell protecting agents into the extracellular and intracellular space of the biological soft tissue; by impregnating the biological soft tissue by applying a vacuum to the biological soft tissue and then releasing the vacuum, wherein the step of applying a vacuum is performed while the biological soft tissue is immersed in an impregnation solution containing said one or more cell protecting agents, and by gradually decreasing the pressure from atmospheric pressure to a minimum pressure in a pressure falling step during a time of from 1 second to 15 minutes, then optionally keeping the minimum pressure in a pressure holding step during a certain time, and then rising the pressure to atmospheric pressure again in a pressure rising step during a time of from 1 second to 15 minutes.
    Type: Application
    Filed: October 23, 2020
    Publication date: February 18, 2021
    Inventors: Eda Demir Westman, Pär Håkan Henriksson, Katarzyna Dymek-Krakowiak, Federico Gomez, Ingegerd Sjöholm, Bengt Ekelund
  • Publication number: 20200281219
    Abstract: The present invention describes a method for treatment of biological soft tissue, said method comprising a step involving pulsed electric field (PEF) treatment to open up the stomata in tissues and a subsequent drying step, wherein the PEF treatment is performed in an electrical field with a field strength in the range of 0.4-1.5 kV/cm to provide enhanced rate of moisture removal during dehydration without irreversible damage on epidermal cells, wherein the PEF treatment is performed with reversible electroporation and wherein the temperature in the drying step is held within the range of 20-55° C.
    Type: Application
    Filed: April 4, 2017
    Publication date: September 10, 2020
    Inventors: Eda DEMIR, Katarzyna DYMEK, Federico GOMEZ, Stephen KWAO, Allan RASMUSSON, Maria Elena VICENTE DAMAS
  • Patent number: 10586238
    Abstract: An automated process to determine whether an image has been modified includes receiving an image (e.g., via a web portal), requesting an image validation service to analyze the image to determine whether the image and/or a subject depicted in the image, has been modified from its original form and, based on the analysis of the image validation service, outputting a likelihood that the image has been modified. The image validation service may analyze the image using one or more operations to determine a likelihood that the image has been modified, and provide an indication of the likelihood that the image has been modified to the web portal. The indication of the likelihood that the image has been modified may be presented on a display via the web portal, and various actions may be suggested or taken based on the likelihood that the image has been modified.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: March 10, 2020
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: James David Morey, Phillip Wade Mendoza, Monte Windsor, Federico Gomez Suarez, Farhan Khan, John Mower, Graham Ramsay
  • Publication number: 20180064124
    Abstract: The present invention describes an apparatus or system for extending shelf life of biological soft tissue, the apparatus includes a holding means; means for introducing one or more cell protecting agents into the extracellular and intracellular space of the biological soft tissue; means for rinsing and means for extended cold storage intended for preservation. Moreover, the present invention also relates to a method for extending shelf life of biological soft tissue, the method includes the steps of introducing one or more cell protecting agents into the extracellular and intracellular space of the biological soft tissue; and extended cold storing of the biological soft tissue intended for preservation of the same; and wherein the method also includes rinsing the biological soft tissue before or after the introducing of one or more cell protecting agents into the extracellular and intracellular space of the biological soft tissue.
    Type: Application
    Filed: March 18, 2016
    Publication date: March 8, 2018
    Inventors: Eda Demir, Pär Håkan Henriksson, Katarzyna Dymek, Federico Gomez, Ingegerd Sjöholm
  • Publication number: 20170372322
    Abstract: An automated process to determine whether an image has been modified includes receiving an image (e.g., via a web portal), requesting an image validation service to analyze the image to determine whether the image and/or a subject depicted in the image, has been modified from its original form and, based on the analysis of the image validation service, outputting a likelihood that the image has been modified. The image validation service may analyze the image using one or more operations to determine a likelihood that the image has been modified, and provide an indication of the likelihood that the image has been modified to the web portal. The indication of the likelihood that the image has been modified may be presented on a display via the web portal, and various actions may be suggested or taken based on the likelihood that the image has been modified.
    Type: Application
    Filed: June 22, 2016
    Publication date: December 28, 2017
    Inventors: James David Morey, Phillip Wade Mendoza, Monte Windsor, Federico Gomez Suarez, Farhan Khan, John Mower, Graham Ramsay
  • Publication number: 20140194632
    Abstract: Natural and synthetic compounds of Formulae Ia-Ie having a lactone structure, in particular Securolide, have been determined to be effective anti-tumor compounds which target the hrad9 gene and/or protein encoded thereby or complex containing the protein and/or the p53 gene and/or protein. Securolide is cytoselective for mutants of hRad9 based on studies conducted in Rad9 mutant yeast strains. Securolide appears to interact with mutant hRad9 in cancer cells to produce DNA lesions which result in apoptosis. Studies have demonstrated that Securolide is useful for treating proliferation disorders such as melanoma, leukemia, breast cancer, lung cancer, ovarian cancer, colon cancer, esophagus cancer, liver cancer, and lymphatic cancer, and to alleviate pain associated with the cancer.
    Type: Application
    Filed: August 5, 2013
    Publication date: July 10, 2014
    Applicant: Magnachem International Laboratories, Inc.
    Inventors: Federico M. Gomez, C. Federico Gomez Garcia-Godoy, David Terrero
  • Patent number: 8563060
    Abstract: The invention relates to a plant food material comprising at least one cryoprotective agent present in the intracellular space of the cells of said plant. The invention also relates to a freezing method for a plant food product comprising the steps of; providing a plant food material comprising at least 70% water, applying a pulsed electrical field to said plant food material, adding a cryoprotective agent to said plant food material, applying a pressure to said plant food material followed by, a resting period of at least 30 minutes and freezing said plant food material. Thereby it is for the first time possible to conserve a plant food material and maintaining the texture as well as the taste of the plant food material.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: October 22, 2013
    Inventors: Petr Dejmek, Ingegerd Sjöholm, Federico Gómez Galindo, Pui Yeu Phoon
  • Patent number: 8546444
    Abstract: Natural and synthetic compounds having a lactone structure methods for alleviation of pain, especially pain associated with disorders such as melanoma, leukemia, breast cancer, lung cancer, ovarian cancer, colon cancer, esophagus cancer, liver cancer, and lymphatic cancer. Initial studies have shown that patients can be taken off of morphine when the preferred alpha-methylene-gamma-butyrolactone is administered in a dosage of between 60 and 120 mg/day intramuscularly.
    Type: Grant
    Filed: May 28, 2012
    Date of Patent: October 1, 2013
    Assignee: Magnachem International Laboratories, Inc.
    Inventors: Federico M. Gomez, C. Federico Gomez Garcia-Godoy
  • Patent number: 8501431
    Abstract: Natural and synthetic compounds of Formulae Ia-Ie having a lactone structure, in particular Securolide, have been determined to be effective anti-tumor compounds which target the hrad9 gene and/or protein encoded thereby or complex containing the protein and/or the p53 gene and/or protein. Securolide is cytoselective for mutants of hRad9 based on studies conducted in Rad9 mutant yeast strains. Securolide appears to interact with mutant hRad9 in cancer cells to produce DNA lesions which result in apoptosis. Studies have demonstrated that Securolide is useful for treating proliferation disorders such as melanoma, leukemia, breast cancer, lung cancer, ovarian cancer, colon cancer, esophagus cancer, liver cancer, and lymphatic cancer, and to alleviate pain associated with the cancer.
    Type: Grant
    Filed: October 26, 2009
    Date of Patent: August 6, 2013
    Assignee: Magnachem International Laboratories, Inc.
    Inventors: David Terrero, Federico M. Gomez, C. Federico Gomez Garcia-Godoy
  • Patent number: 8188145
    Abstract: Natural and synthetic compounds having a lactone structure methods for alleviation of pain, especially pain associated with disorders such as melanoma, leukemia, breast cancer, lung cancer, ovarian cancer, colon cancer, esophagus cancer, liver cancer, and lymphatic cancer. Initial studies have shown that patients can be taken off of morphine when the preferred alpha-methylene-gamma-butyrolactone is administered in a dosage of between 60 and 120 mg/day intramuscularly.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: May 29, 2012
    Assignee: Magnachem International Laboratories, Inc.
    Inventors: Federico M. Gomez, C. Federico Gomez Garcia-Godoy
  • Publication number: 20100227030
    Abstract: The invention relates to a plant food material comprising at least one cryoprotective agent present in the intracellular space of the cells of said plant. The invention also relates to a freezing method for a plant food product comprising the steps of; providing a plant food material comprising at least 70% water, applying a pulsed electrical field to said plant food material, adding a cryoprotective agent to said plant food material, applying a pressure to said plant food material followed by, a resting period of at least 30 minutes and freezing said plant food material.
    Type: Application
    Filed: October 3, 2008
    Publication date: September 9, 2010
    Inventors: Federico Gómez Galindo, Pui Yeu Phoon
  • Publication number: 20100137618
    Abstract: Natural and synthetic compounds of Formulae Ia-Ie having a lactone structure, in particular Securolide, have been determined to be effective anti-tumor compounds which target the hrad9 gene and/or protein encoded thereby or complex containing the protein and/or the p53 gene and/or protein. Securolide is cytoselective for mutants of hRad9 based on studies conducted in Rad9 mutant yeast strains. Securolide appears to interact with mutant hRad9 in cancer cells to produce DNA lesions which result in apoptosis. Studies have demonstrated that Securolide is useful for treating proliferation disorders such as melanoma, leukemia, breast cancer, lung cancer, ovarian cancer, colon cancer, esophagus cancer, liver cancer, and lymphatic cancer, and to alleviate pain associated with the cancer.
    Type: Application
    Filed: October 26, 2009
    Publication date: June 3, 2010
    Inventors: Federico M. Gomez, C. Federico Gomez Garcia-Godoy, David Terrero
  • Publication number: 20090316961
    Abstract: A computer based method for facilitating tagging of an input image is disclosed. The method includes receiving an input image which has a content including at least a facial image or a plurality of facial images. From this input image, facial recognition techniques are used to identify where in the image the faces are located. When a facial image is detected, the facial image may be displayed to the user as an individual facial image which substantially consists of a face. This display helps facilitate tagging of the individual facial image and also tagging of the input image. A user may input a tag for the individual facial image and the input image. Also, a user may be presented with contact information which is likely to include a name of a person which can be selected as a tag for the individual facial image and/or also the input image.
    Type: Application
    Filed: June 21, 2008
    Publication date: December 24, 2009
    Applicant: MICROSOFT CORPORATION
    Inventors: Federico Gomez Suarez, Anthony DiCola
  • Publication number: 20050239877
    Abstract: Natural and synthetic compounds having a lactone structure methods for alleviation of pain, especially pain associated with disorders such as melanoma, leukemia, breast cancer, lung cancer, ovarian cancer, colon cancer, esophagus cancer, liver cancer, and lymphatic cancer. Initial studies have shown that patients can be taken off of morphine when the preferred alpha-methylene-gamma-butyrolactone is administered in a dosage of between 60 and 120 mg/day intramuscularly.
    Type: Application
    Filed: April 18, 2005
    Publication date: October 27, 2005
    Inventors: Federico Gomez, C. Garcia Gomez-Godoy
  • Patent number: 6054478
    Abstract: Compounds of the formula (I) ##STR1## and pharmaceutically acceptable salts or metabolically labile derivatives thereof, processes for their preparation, their use as antifungal agents and intermediates for use in their preparation.
    Type: Grant
    Filed: July 16, 1997
    Date of Patent: April 25, 2000
    Assignee: Glaxo Wellcome S.A.
    Inventors: Jose J. Martin, Jesus Chicharro Gonzalo, Jose R. R. Gomez, Silvestre Garcia-Ochoa Dorado, Federico Gomez De Las Heras, Michael V. Hayes, Michael J. Dawson, Howard G. Wildman, Richard M. Hall